HbA1c measurement.
作者信息
Kilpatrick E S
出版信息
J Clin Pathol. 2004 Apr;57(4):344-5. doi: 10.1136/jcp.2003.010918.
Abstract
摘要
相似文献
1
HbA1c measurement.糖化血红蛋白（HbA1c）检测
J Clin Pathol. 2004 Apr;57(4):344-5. doi: 10.1136/jcp.2003.010918.
2
[Determination of glycated hemoglobins (Hb A1c)].[糖化血红蛋白（Hb A1c）的测定]
Wien Klin Wochenschr. 2002 May 15;114(8-9):301-5.
3
[Is HbA1c suitable for diagnosis of diabetes? Pro].糖化血红蛋白A1c是否适用于糖尿病诊断？正方观点
Dtsch Med Wochenschr. 2011 May;136(21):1128. doi: 10.1055/s-0031-1280523. Epub 2011 May 17.
4
[Is HbA1c suitable for diagnosis of diabetes? Contra].
Dtsch Med Wochenschr. 2011 May;136(21):1129. doi: 10.1055/s-0031-1280524. Epub 2011 May 17.
5
2013 update on the worldwide standardization of the HbA1c measurement.2013年糖化血红蛋白（HbA1c）测量全球标准化更新
Diabet Med. 2013 Jul;30(7):885-6. doi: 10.1111/dme.12204. Epub 2013 May 1.
6
Interpretation of hemoglobin A1c values.糖化血红蛋白值的解读。
JAMA. 2014 Jun 11;311(22):2271-2. doi: 10.1001/jama.2014.6342.
7
Accuracy of filter paper method for measuring glycated hemoglobin.滤纸法测定糖化血红蛋白的准确性。
J Assoc Physicians India. 2007 Feb;55:115-9.
8
Detection of diabetes and prediabetes using glycosylated hemoglobin in Chinese adults living in Shanghai: A prospective analysis.应用糖化血红蛋白检测上海地区成年居民糖尿病和糖尿病前期：前瞻性分析。
J Diabetes. 2020 Aug;12(8):573-582. doi: 10.1111/1753-0407.13028. Epub 2020 Mar 12.
9
Evaluation of glycaemic control limits.
Diabet Med. 1994 Aug-Sep;11(7):715. doi: 10.1111/j.1464-5491.1994.tb00340.x.
10
Diabetes diagnostic thresholds of the glycated hemoglobin A1c and fasting plasma glucose levels considering the 5-year incidence of retinopathy.考虑视网膜病变5年发病率的糖化血红蛋白A1c和空腹血糖水平的糖尿病诊断阈值。
Diabetes Res Clin Pract. 2017 Feb;124:20-29. doi: 10.1016/j.diabres.2016.12.013. Epub 2016 Dec 27.
引用本文的文献
1
Psychometric properties of the EQ-5D-5L in diabetes mellitus patients in Spain.西班牙糖尿病患者中EQ-5D-5L量表的心理测量学特性
J Patient Rep Outcomes. 2025 May 29;9(1):60. doi: 10.1186/s41687-025-00874-5.
2
There is no dose-response relationship between the amount of exercise and improvement in HbA1c in interventions over 12 weeks in patients with type 2 diabetes: a meta-analysis and meta-regression.在 12 周以上的 2 型糖尿病患者干预中，运动剂量与 HbA1c 改善之间不存在量效关系：一项荟萃分析和荟萃回归。
Acta Diabetol. 2022 Nov;59(11):1399-1415. doi: 10.1007/s00592-022-01918-8. Epub 2022 Aug 5.
3
Achieving the HbA1c Target Requires Longer Time in Range in Pregnant Women With Type 1 Diabetes.实现 HbA1c 目标需要 1 型糖尿病孕妇的血糖在目标范围内维持更长时间。
J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4309-e4317. doi: 10.1210/clinem/dgab502.
4
Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters.1 型糖尿病妊娠的连续血糖监测目标：每 5%的时间在目标范围内很重要。
Diabetologia. 2019 Jul;62(7):1123-1128. doi: 10.1007/s00125-019-4904-3. Epub 2019 Jun 3.
5
Single-Use Disposable Electrochemical Label-Free Immunosensor for Detection of Glycated Hemoglobin (HbA1c) Using Differential Pulse Voltammetry (DPV).用于检测糖化血红蛋白（HbA1c）的一次性使用电化学免标记免疫传感器，采用差分脉冲伏安法（DPV）。
Sensors (Basel). 2016 Jul 1;16(7):1024. doi: 10.3390/s16071024.
6
Morphologic and cytomorphometric analysis of exfoliated buccal mucosal cells in diabetes patients.糖尿病患者颊黏膜脱落细胞的形态学和细胞形态计量学分析
J Cytol. 2010 Oct;27(4):113-7. doi: 10.4103/0970-9371.73291.
7
The proposed terminology 'A(1c)-derived average glucose' is inherently imprecise and should not be adopted.所提议的术语“A（1c）衍生平均血糖”本质上不精确，不应采用。
Diabetologia. 2008 Jul;51(7):1111-4. doi: 10.1007/s00125-008-1027-7. Epub 2008 May 1.
8
Glycated haemoglobin (HbA1c) monitoring.糖化血红蛋白（HbA1c）监测。
BMJ. 2006 Sep 16;333(7568):586-8. doi: 10.1136/bmj.38947.627847.AE.
9
Best practice in primary care pathology: review 3.基层医疗病理学的最佳实践：综述3
J Clin Pathol. 2006 Aug;59(8):781-9. doi: 10.1136/jcp.200X.033944.
本文引用的文献
1
Conditions associated with very low values of glycohaemoglobin measured by an HPLC method.通过高效液相色谱法测得的糖化血红蛋白值极低时相关的情况。
J Clin Pathol. 2004 Apr;57(4):346-9. doi: 10.1136/jcp.2002.007088.
2
Approved IFCC reference method for the measurement of HbA1c in human blood.国际临床化学和检验医学联合会（IFCC）批准的人血中糖化血红蛋白A1c（HbA1c）测量参考方法。
Clin Chem Lab Med. 2002 Jan;40(1):78-89. doi: 10.1515/CCLM.2002.016.
3
Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.界定血浆葡萄糖与糖化血红蛋白（HbA₁c）之间的关系：糖尿病控制与并发症试验中葡萄糖谱和糖化血红蛋白（HbA₁c）的分析
Diabetes Care. 2002 Feb;25(2):275-8. doi: 10.2337/diacare.25.2.275.
4
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.血糖水平与2型糖尿病大血管及微血管并发症的关联（英国前瞻性糖尿病研究35）：前瞻性观察研究
BMJ. 2000 Aug 12;321(7258):405-12. doi: 10.1136/bmj.321.7258.405.
5
Standardization of HbA1c measurements--a consensus statement.糖化血红蛋白（HbA1c）测量的标准化——共识声明
Diabet Med. 2000 Jan;17(1):5-6. doi: 10.1046/j.1464-5491.2000.00228.x.
6
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较（英国前瞻性糖尿病研究[UKPDS 33]）。英国前瞻性糖尿病研究（UKPDS）小组
Lancet. 1998 Sep 12;352(9131):837-53.
7
Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring.糖化血红蛋白的生物学变异。对糖尿病筛查和监测的意义。
Diabetes Care. 1998 Feb;21(2):261-4. doi: 10.2337/diacare.21.2.261.
8
Problems in the assessment of glycaemic control in diabetes mellitus.糖尿病血糖控制评估中的问题
Diabet Med. 1997 Oct;14(10):819-31. doi: 10.1002/(SICI)1096-9136(199710)14:10<819::AID-DIA459>3.0.CO;2-A.
9
10
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.糖尿病强化治疗对胰岛素依赖型糖尿病长期并发症发生及进展的影响。
N Engl J Med. 1993 Sep 30;329(14):977-86. doi: 10.1056/NEJM199309303291401.
Zotero 插件